Efficacy and safety of haloperidol prophylaxis for delirium prevention in older medical and surgical at-risk patients acutely admitted to hospital through the emergency department: study protocol of a multicenter, randomised, double-blind, placebo-controlled clinical trial

BMC Geriatrics

Prabath WB Nanayakkara⁷  Mark HH Kramer⁶  Douwe Pons⁸  Leo Boelaarts⁸  Astrid M van Strien^1,11  Rob J van Marum^1,11  Anne M Lagaay²  Esther Kuipéri¹  Andrea Siegel⁴  Sander Anten⁴  Sabine HA Diepeveen⁹  Ad M Kamper^1,10  Peter M van de Ven⁵  Pierre M Bet³  Karola de Graaf⁶  Astrid Verburg^1,12  Oscar J de Vries^1,12  Edmée JM Schrijver⁶ 

[1] Currently: specialist training in General Practice at Leiden University Medical Center, Leiden, The Netherlands;Section of Geriatrics, Department of Internal Medicine, Spaarne Hospital, Hoofddorp, The Netherlands;Department of Clinical Pharmacology and Pharmacy, VU University Medical Center, Amsterdam, The Netherlands;Department of Internal Medicine, Rijnland Hospital, Leiderdorp, The Netherlands;Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands;Department of Internal Medicine, VU University Medical Center, Amsterdam, The Netherlands;Section of Acute Medicine, Department of Internal Medicine, VU University Medical Center, Amsterdam, The Netherlands;Department of Geriatric Medicine, Medical Centre Alkmaar, Alkmaar, The Netherlands;Section of Acute Medicine, Department of Internal Medicine, Isala Hospital, Zwolle, The Netherlands;Section of Geriatrics, Department of Internal Medicine, Isala Hospital, Zwolle, The Netherlands;Department of Geriatric Medicine, Jeroen Bosch Hospital, ’s Hertogenbosch, The Netherlands;Section of Geriatrics, Department of Internal Medicine, VU University Medical Center, Amsterdam, The Netherlands

关键词: Older patients;    Prophylactic treatment;    Delirium;    Haloperidol;   

Others  :  1090027
DOI  :  10.1186/1471-2318-14-96

 received in 2013-08-02, accepted in 2014-08-20,  发布年份 2014

【 摘 要 】

Background

Delirium is associated with substantial morbidity and mortality rates in elderly hospitalised patients, and a growing problem due to increase in life expectancy. Implementation of standardised non-pharmacological delirium prevention strategies is challenging and adherence remains low. Pharmacological delirium prevention with haloperidol, currently the drug of choice for delirium, seems promising. However, the generalisability of randomised controlled trial results is questionable since studies have only been performed in selected postoperative hip-surgery and intensive care unit patient populations. We therefore present the design of the multicenter, randomised, double-blind, placebo-controlled clinical trial on early pharmacological intervention to prevent delirium: haloperidol prophylaxis in older emergency department patients (The HARPOON study).

Methods/Design

In six Dutch hospitals, at-risk patients aged 70 years or older acutely admitted through the emergency department for general medicine and surgical specialties are randomised (n = 390) for treatment with prophylactic haloperidol 1 mg or placebo twice daily for a maximum of seven consecutive days. Primary outcome measure is the incidence of in-hospital delirium within seven days of start of the study intervention, diagnosed with the Confusion Assessment Method, and the Diagnostic and Statistical Manual of Mental Disorders, fourth edition criteria for delirium. Secondary outcome measures include delirium severity and duration assessed with the Delirium Rating Scale Revised 98; number of delirium-free days; adverse events; hospital length-of-stay; all-cause mortality; new institutionalisation; (Instrumental) Activities of Daily Living assessed with the Katz Index of ADL, and Lawton IADL scale; cognitive function assessed with the Six-item Cognitive Impairment Test, and the Dutch short form Informant Questionnaire on Cognitive Decline in the Elderly. Patients will be contacted by telephone three and six months post-discharge to collect data on cognitive- and physical function, home residency, all-cause hospital admissions, and all-cause mortality.

Discussion

The HARPOON study will provide relevant information on the efficacy and safety of prophylactic haloperidol treatment for in-hospital delirium and its effects on relevant clinical outcomes in elderly at-risk medical and surgical patients.

Trial registration

EudraCT Number: 201100476215; ClinicalTrials.gov Identifier:NCT01530308; Dutch Clinical Trial Registry:NTR3207

【 授权许可】

   
2014 Schrijver et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Ryan DJ, O’Regan NA, Caoimh RO, Clare J, O’Connor M, Leonard M, McFarland J, Tighe S, O’Sullivan K, Trzepacz PT, Meagher D, Timmons S: Delirium in an adult acute hospital population: predictors, prevalence and detection. BMJ Open 2013, 3:e001772.
• [2]American Psychiatric Association: Practice guideline for the treatment of patients with delirium. Am J Psychiatry 1999, 156:1-20.
• [3]Travers C, Byrne G, Pachana N, Klein K, Gray L: Prospective observational study of dementia and delirium in the acute hospital setting. Intern Med J 2013, 43:262-269.
• [4]Inouye SK, Rushing JT, Foreman MD, Palmer RM, Pompei P: Does delirium contribute to poor hospital outcomes? A three-site epidemiologic study. J Gen Intern Med 1998, 13:234-242.
• [5]Kat MG, Vreeswijk R, de Jonghe JFM, van der Ploeg T, van Gool WA, Eikelenboom P, Kalisvaart KJ: Long-term cognitive outcome of delirium in elderly hip surgery patients. A prospective matched controlled study over two and a half years. Dement Geriatr Cogn Disord 2008, 26:1-8.
• [6]McAvay GJ, Van Ness PH, Bogardus ST Jr, Zhang Y, Leslie DL, Leo-Summers LS, Inouye SK: Older adults discharged from the hospital with delirium: 1-year outcomes. J Am Geriatr Soc 2006, 54:1245-1250.
• [7]Leslie DL, Marcantonio ER, Zhang Y, Leo-Summers L, Inouye SK: One-year health care costs associated with delirium in the elderly population. Arch Intern Med 2008, 168:27-32.
• [8]Inouye SK, Bogardus ST Jr, Charpentier PA, Leo-Summers L, Acampora D, Holford TR, Cooney LM Jr: A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med 1999, 340:669-676.
• [9]de Castro MM, Unlu C, Tuynman B, Honig A, van Wagensveld BA, Steller EP, Vrouenraets C: Incidence and risk factors of delirium in the elderly general surgical patient. Am J Surg 2014, 208:26-32.
• [10]Inouye SK, Bogardus ST Jr, Williams CS, Leo-Summers L, Agostini JV: The role of adherence on the effectiveness of nonpharmacologic interventions: evidence from the delirium prevention trial. Arch Intern Med 2003, 163:958-964.
• [11]Bogardus ST Jr, Desai MM, Williams CS, Leo-Summers L, Acampora D, Inouye SK: The effects of a targeted multicomponent delirium intervention on postdischarge outcomes for hospitalized older adults. Am J Med 2003, 114:383-390.
• [12]Kaneko T, Cai J, Ishikura T, Kobayashi M, Naka T, Kaibara N: Prophylactic consecutive administration of haloperidol can reduce the occurrence of postoperative delirium in gastrointestinal surgery. Yonago Acta Medica 1999, 42:179-184.
• [13]Wang W, Li HL, Wang DX, Zhu X, Li SL, Yao GQ, Chen KS, Gu XE, Zhu SN: Haloperidol prophylaxis decreases delirium incidence in elderly patients after noncardiac surgery: a randomized controlled trial*. Crit Care Med 2012, 40:731-739.
• [14]Kalisvaart KJ, de Jonghe JFM, Bogaards MJ, Vreeswijk R, Egberts TCG, Burger BJ, Eikelenboom P, van Gool WA: Haloperidol prophylaxis for elderly hip-surgery patients at risk for delirium: a randomized placebo-controlled study. J Am Geriatr Soc 2005, 53:1658-1666.
• [15]Dutch Hospital Patient Safety Program (VMS Veiligheidsprogramma) http://www.vmszorg.nl/ webcite
• [16]World Health Organization: International Statistical Classification of Diseases (ICD) and Related Health Problems, 10th Revision. Geneva: World Health Organization; 2010.
• [17]WHO Collaborating Centre for Drug Statistics Methodology: Guidelines for ATC classification and DDD assignment 2013. Oslo: WHO Collaborating Centre for Drug Statistics Methodology; 2012.
• [18]Charlson ME, Sax FL, MacKenzie CR, Fields SD, Braham RL, Douglas RG Jr: Assessing illness severity: does clinical judgment work? J Chronic Dis 1986, 39:439-452.
• [19]Sundararajan V, Henderson T, Perry C, Muggivan A, Quan H, Ghali WA: New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. J Clin Epidemiol 2004, 57:1288-1294.
• [20]Katz S: Assessing self-maintenance: activities of daily living, mobility, and instrumental activities of daily living. J Am Geriatr Soc 1983, 31:721-727.
• [21]Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW: Studies of illness in the aged. The index of ADL: A standardized measure of biological and psychosocial function. JAMA 1963, 185:914-919.
• [22]Lawton MP, Brody EM: Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969, 9:179-186.
• [23]Tuijl JP, Scholte EM, de Craen AJ, van der Mast RC: Screening for cognitive impairment in older general hospital patients: comparison of the Six-Item Cognitive Impairment Test with the Mini-Mental State Examination. Int J Geriatr Psychiatry 2012, 27:755-762.
• [24]Brooke P, Bullock R: Validation of a 6 item cognitive impairment test with a view to primary care usage. Int J Geriatr Psychiatry 1999, 14:936-940.
• [25]Upadhyaya AK, Rajagopal M, Gale TM: The Six Item Cognitive Impairment Test (6-CIT) as a screening test for dementia: comparison with Mini-Mental State Examination (MMSE). Curr Aging Sci 2010, 3:138-142.
• [26]Jorm AF: The Informant Questionnaire on cognitive decline in the elderly (IQCODE): a review. Int Psychogeriatr 2004, 16:275-293.
• [27]Laurila JV, Pitkala KH, Strandberg TE, Tilvis RS: Confusion assessment method in the diagnostics of delirium among aged hospital patients: would it serve better in screening than as a diagnostic instrument? Int J Geriatr Psychiatry 2002, 17:1112-1119.
• [28]Schuurmans MJ, Deschamps PI, Markham SW, Shortridge-Baggett LM, Duursma SA: The measurement of delirium: review of scales. Res Theory Nurs Pract 2003, 17:207-224.
• [29]Schuurmans MJ, Shortridge-Baggett LM, Duursma SA: The Delirium Observation Screening Scale: a screening instrument for delirium. Res Theory Nurs Pract 2003, 17:31-50.
• [30]Trzepacz PT, Mittal D, Torres R, Kanary K, Norton J, Jimerson N: Validation of the Delirium Rating Scale-revised-98: comparison with the delirium rating scale and the cognitive test for delirium. J Neuropsychiatry Clin Neurosci 2001, 13:229-242.
• [31]Katznelson R, Djaiani G, Tait G, Wasowicz M, Sutherland AM, Styra R, Lee C, Beattie WS: Hospital administrative database underestimates delirium rate after cardiac surgery. Can J Anaesth 2010, 57:898-902.
• [32]Maneeton B, Maneeton N, Srisurapanont M, Chittawatanarat K: Quetiapine versus haloperidol in the treatment of delirium: a double-blind, randomized, controlled trial. Drug Des Dev Ther 2013, 7:657-667.
• [33]Nakamura J, Uchimura N, Yamada S, Nakazawa Y: Does plasma free-3-methoxy-4-hydroxyphenyl(ethylene)glycol increase in the delirious state? A comparison of the effects of mianserin and haloperidol on delirium. Int Clin Psychopharmacol 1997, 12:147-152.
• [34]Donders E, Tillemans M, Vreeswijk R, Grootendorst D, Kalisvaart K: Effect of haloperidol dosing frequencies on the duration and severity of delirium in elderly hip fracture patients. A prospective randomized trial. Eur Geriatr Med 2012, 3:S118-S119.
• [35]Warren SR, Raisch DW, Campbell HM, Guarino PD, Kaufman JS, Petrokaitis E, Goldfarb DS, Gaziano JM, Jamison RL: Medication adherence assessment in a clinical trial with centralized follow-up and direct-to-patient drug shipments. Clin Trials 2013, 10:441-448.
• [36]Drew BJ, Ackerman MJ, Funk M, Gibler WB, Kligfield P, Menon V, Philippides GJ, Roden DM, Zareba W: Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. J Am Coll Cardiol 2010, 55:934-947.
• [37]Drew BJ, Califf RM, Funk M, Kaufman ES, Krucoff MW, Laks MM, Macfarlane PW, Sommargren C, Swiryn S, Van Hare GF: Practice standards for electrocardiographic monitoring in hospital settings: an American Heart Association scientific statement from the Councils on Cardiovascular Nursing, Clinical Cardiology, and Cardiovascular Disease in the Young: endorsed by the International Society of Computerized Electrocardiology and the American Association of Critical-Care Nurses. Circulation 2004, 110:2721-2746.
• [38]Goldberger JJ, Cain ME, Hohnloser SH, Kadish AH, Knight BP, Lauer MS, Maron BJ, Page RL, Passman RS, Siscovick D, Stevenson WG, Zipes DP: American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death. A scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention. J Am Coll Cardiol 2008, 52:1179-1199.
• [39]Callahan CM, Unverzagt FW, Hui SL, Perkins AJ, Hendrie HC: Six-item screener to identify cognitive impairment among potential subjects for clinical research. Med Care 2002, 40:771-781.
• [40]Ciesla JR, Shi L, Stoskopf CH, Samuels ME: Reliability of Katz’s Activities of Daily Living Scale when used in telephone interviews. Eval Health Prof 1993, 16:190-203.